期刊文献+

内皮细胞微粒对人脐静脉内皮细胞ICAM-1表达和NF-κB活性的影响 被引量:2

Effects of endothelial microparticles on ICAM-1 expression and NF-κB activity in HUVECs
下载PDF
导出
摘要 目的探讨内皮细胞微粒(EMPs)对人脐静脉内皮细胞(HUVECs)核转录因子-κB(NF-κB)活性变化及细胞间黏附分子-1(ICAM-1)表达的影响。方法将体外培养的HU-VECs分3大组:①EMPs不同时点观察组:用EMPs(终浓度105/ml)分别刺激细胞0、3、6、12、24 h;②EMPs不同剂量作用组:分别用终浓度为0、102、103、104、105/ml的EMPs刺激细胞24 h;③二硫代氨基甲酸吡咯烷(PDTC)干预组:在EMPs(终浓度105/ml)刺激前,与终浓度为10μmol/L的PDTC共同孵育30 min。用实时荧光定量PCR测定ICAM-1mRNA的表达,Western blot测定核蛋白NF-κB p65和ICAM-1蛋白的表达。结果 EMPs可通过活化NF-κB,使ICAM-1mRNA和蛋白呈剂量和时间依赖性表达上调。NF-κB特异性拮抗剂PDTC可显著抑制EMPs的此作用。结论在EMPs诱导的HUVECs炎性效应中,NF-κB参与调控炎性因子ICAM-1的表达。 Objective To explore the role of nuclear factor-κB (NF-κB) in expressing of intercellular adhesionmolecule 1 (ICAM-1) in cultured human umbilical vein endothelial cells (HUVECs) activated by endothelial mi- croparticles (EMPs). Methods The cultured HUVECs were divided into three groups: different time points (0, 3, 6, 12, 24 h) of the observation group with EMPs of 105/ml; different doses of EMPs (0,102, 103, 104, 105/ml)with a fixed stimulation time of 24 h ; EMPs with the specific inhibitor of NF-κB p65, pyrrolidine dithiocarbamic acid (PDTC). The ICAM-1 mRNA level was detected by quantitative real-time reverse transcriptase polymerase chain reaction (qRT-PCR). Western blot analysis was performed to determine expression levels of NF-κB p65 and ICAM-1 protein. Results NF-κB activity and the expressions of ICAM-1 increased after the HUVECs were treated by EMPs in a dose-dependent and time-dependent manner. The expressions of ICAM-1 weakened after being trea- ted with PDTC. Conclusion NF-κB controlled the expression of proinflammatory cytokine ICAM-1 in the EMPs induced inflammatory effects on 1-IUVECs.
出处 《安徽医科大学学报》 CAS 北大核心 2012年第11期1291-1295,共5页 Acta Universitatis Medicinalis Anhui
基金 广西自然科学基金青年基金(编号:2012GXNSFBA053113) 广西壮族自治区卫生厅自筹经费科研课题(编号:Z2011103)
关键词 内皮细胞微粒 脐静脉内皮细胞 核转录因子-ΚB 细胞间黏附分子-1 endothelial microparticles human umbilical vein endothelial cells nuclear factor-κB intercellularadhesion molecule 1
  • 相关文献

参考文献10

  • 1Boulanger C M, Leroyer A S, Amabile N, et al. Circulating endo- thelial microparticles: a new marker of vascular injury [ J]. Ann Cardiol Angeiol, 2008, 57 ( 3 ) : 149 - 54.
  • 2Martinez M C, Tual-Chalot S, Leonetti D, et al. Microparticles:targets and tools in cardiovascular disease [ J ]. Trends Pharmacol Sci, 2011, 32(11): 659-65.
  • 3Tarin C, Gomez M, Calvo E, et al. Endothelial nitric oxide deficiency reduces MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: a role in atherosclerosis [ J]. Artefioscler Thromb Vasc Biol, 2009, 29(1) : 27 -32.
  • 4Roh H C, Yoo do Y, Ko S H, et al. Bacteroides fragilis enterotox- in upregulates intercellular adhesion molecule-I in endothelial cells via an aldose reductase- MAPK-, and NF-kappaB-dependent pathway, leading to monocyte adhesion to endothelial cells [ J]. J Immunol, 2011, 187(4) : 1931 -41.
  • 5Terrisse A D, Puech N, Allart S, et al. Internalization of microp- articles by endothelial eel.Is promotes platelet/endothelial cell interaction under flow [J]. J Thromb Haemost, 2010, 8(12) : 2810 --9.
  • 6Chironi G N, Boulanger C M, Simon A, et al. Endothelial micro- particles in diseases [ J]. Cell Tissue Res, 2009, 335 ( 1 ) : 143 - 51.
  • 7Hartford M, Wiklund O, Mattsson Hulton L, et al. C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes [ J ]. J Intern Med, 2007, 262(5) : 526 -36.
  • 8Patti G, Chello M, Gatto L, et al. Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Resuits from the ARMYDA-ACS CAMs ( atorvastatin for reduction of myocardial damage during angioplasty-cell adhesion molecules ) substudy [ J]. J Cardiovasc Med (Hagerstown) , 2010, 11 (11 ): 795 - 800.
  • 9刘皆,叶山东,胡圆圆,徐将,董崇周.螺内酯对醛固酮诱导的大鼠肾小球系膜细胞氧化应激及NF-κB、MCP-1表达的影响[J].安徽医科大学学报,2012,47(1):15-19. 被引量:10
  • 10Pamukcu B, Lip G Y, Shantsila E. The nuclear factor - kappa B pathway in atherosclemsis : a potential therapeutic target for athero- thrombotic vascular disease [ J ]. Thromb Res, 2011, 128 ( 2 ) : 117 -23.

二级参考文献11

共引文献9

同被引文献33

  • 1Chironi GN,Boulanger CM,Simon A, et al. Endothelial mieropar- ticles in diseases[J]. Cell Tissue Res,2009,335(1):143- 151.
  • 2Morel O, Morel N, Jesel L, et al. Microparticles ; a critical compo nent in the nexus between inflammation,immunity, and thrombo sis[J]. Semin Immunopathol,2011,33(5) :469- 486.
  • 3Dignat-George F,Boulanger CM. The many faces of endothelial microparticles[J ]. Arterioscler Thromb Vasc Biol, 2011,31 ( 1 ) : 27-33.
  • 4Viera A J, Mooberry M, Key NS, et ai. Microparticles in cardiovas- cular disease pathophysiology and outeomes[J]. J Am Soc Hyper- tens,2012,6(4) :243-252.
  • 5Wu ZH,Ji CL, Li H,et al. Membrane microparticles and diseases[J]. Eur Rev Med Pharmacol Sci,2013,17(18) :2420-2427.
  • 6Martinez MC, Tual-Chalot S, Leonetti D, el al. Microparticles: targets and tools in cardiovascular disease[J]. Trends Pharmacol Sci,2011,32(11) :659-665.
  • 7Markiewicz M, Richard E, Marks N, et al. Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases [J]. J Aging Res, 2013, 2013: 734509.
  • 8Eyre J, Burton JO,Saleem MA, et al. Monocyte- and Endothelial Derived microparticles induce an inflammatory phenotype in hu- man podocytes[J]. Nephron Exp Nephrol,2011,119(3) :58-66.
  • 9Burger D, Touyz RM. Cellular biomarkers of endothelial health: microparticles,endothelial progenitor ceils, and circulating endo thelial cells[J]. J Am Soc Hypertens, 2012,6 (2) : 85- 99.
  • 10Mezentsev A, Merks RM,O'Riordan E, et al. Endothelial mierop articles affect angiogenesis in vitro: role of oxidative stress[J]. Am J Physiol Heart Circ Physiol,2005,289(3) : 1106-1114. 2013,35(1) ,104-106.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部